Real-time enrollment status for this bronchiectasis clinical trial
Current Status
Recruiting
Checked: July 18, 2026 at 6:52 AM UTC
| NCT Number | NCT06872892 |
| Recruiting Status | Recruiting |
| Condition | Bronchiectasis |
| Phase | PHASE3 |
| Target Enrollment | 1,755 participants |
| Active Locations | 80 sites in the US |
| Sponsor | Boehringer Ingelheim |
| Last Updated on CT.gov | July 9, 2026 (1 week ago) |
As of July 18, 2026: Clinical trial NCT06872892 is currently recruiting participants. This phase3 study for bronchiectasis is actively seeking new participants at 80 locations across the United States. The study is sponsored by Boehringer Ingelheim. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06872892 is actively recruiting participants as of July 18, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 80 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06872892 was last updated 1 week ago (July 9, 2026). HelloStudys verifies this status automatically.